Edinburgh Research Explorer

Prof Peter Sandercock

Professorial Fellow

  1. 2019
  2. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial

    The CRASH-3 trial collaborators, 14 Oct 2019, In : The Lancet. 394, 10210, p. 1713-1723

    Research output: Contribution to journalArticle

  3. How can the World Stroke Organization (WSO) optimize education in stroke medicine around the world? Report of the 2018 WSO Global Stroke Stakeholder Workshop

    Gubitz, G., Saini, M., Belson, S., Sahathevan, R. & Sandercock, P., 10 Sep 2019, In : International Journal of Stroke.

    Research output: Contribution to journalComment/debate

  4. Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial

    Dennis, M., Forbes, J., Graham, C., Hackett, M. L., Hankey, G. J., House, A., Lewis, S., Lundström, E., Sandercock, P. & Mead, G., 20 Aug 2019, In : Stroke.

    Research output: Contribution to journalArticle

  5. Stroke in China: advances and challenges in epidemiology, prevention, and management

    China Stroke Study Collaboration, 14 Mar 2019, In : Lancet Neurology. 18, 4, p. 394-405

    Research output: Contribution to journalArticle

  6. 2018
  7. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

    FOCUS Trial Collaboration, Dennis, M., Forbes, J., Graham, C., Hackett, M. L., Hankey, G., House, A., Lewis, S., Lundstrom, E. & Mead, G., 5 Dec 2018, In : The Lancet.

    Research output: Contribution to journalArticle

  8. World Stroke Day – a day of global action

    Sandercock, P., 29 Oct 2018, In : Stroke.

    Research output: Contribution to journalEditorial

Previous 1 2 3 4 5 6 7 8 ...24 Next